Fig. 5.
Fig. 5. Kaplan-Meier plot of actuarial EFS for DS and non-DS patients with and without trisomy 21 in the leukemic clone. EFS in DS, tetrasomy 21 is 100%; DS, trisomy 21, 69% (CI95, 45%-85%); non-DS trisomy 21, 22% (4%-66%); non-DS disomy 21 (CI95, 32%-46%).

Kaplan-Meier plot of actuarial EFS for DS and non-DS patients with and without trisomy 21 in the leukemic clone. EFS in DS, tetrasomy 21 is 100%; DS, trisomy 21, 69% (CI95, 45%-85%); non-DS trisomy 21, 22% (4%-66%); non-DS disomy 21 (CI95, 32%-46%).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal